Europe Intraocular Lens Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Europe Intraocular Lens market is segmented by Product (Monofocal, Accommodative, Multifocal, and Toric Intraocular Lens), End User, and Geography

Market Snapshot

Picture1 Europe Intraocular Lens Market
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The growth of the European intraocular lens market is due to the rising number of ophthalmic disorders and ageing population. The rising prevalence of ocular conditions, such as cataract and diabetic retinopathy across the world, is driving the market’s growth.

Around 34 million people in the European Union (EU) are affected by age-related macular degeneration, as stated by EURETINA, in 2017. Similarly According to the European Society of Retinal Specialists, in 2017, the prevalence rate of age-related macular degeneration was accounted to be approximately 32.8% in Germany.​

Other factors, such as increasing cases of cataract in the diabetic population, is leading to the rising adoption of advanced premium intraocular lens, are likely to propel the growth of the European intraocular lens market. However, the high cost of the intraocular lens and poor reimbursement coverage is expected to hamper the market’s growth during the forecast period.

Scope of the Report

Intraocular lenses are implanted in the eyes of people who suffer from cataracts or myopia and seek surgery for the same. Several types of intraocular lenses are available in the market, which are primarily meant to improve vision.

Monofocal Intraocular Lens
Accommodative Intraocular Lens
Multifocal Intraocular Lens
Toric Intraocular Lens
End Users
Ophthalmic Clinics
Ambulatory Clinics
Research Institutes
United Kingdom
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Toric Intraocular Lens Segment is expected to Experience the Signinficant Rate

Toric intraocular lens is used in cataract surgeries like conventional IOLs, for a couple of important differences like obtaining the measurements prior to surgery, enables the patients to choose the correct lens for getting maximum benefits.​

Toric intraocular lens is available in different powers in different meridians and is used for correcting the asymmetric power of the eye observed in astigmatism.​ Toric IOLs are special as they have certain markers on the peripheral parts of the lens to enable the surgeon to see the orientation of the astigmatism correction in the lens. ​The surgeon who performs surgeries using toric lenses can adjust the orientation of the lens to correct astigmatism after the implantation to obtain the best results.​

Furthermore, Toric lens is the most preferred, as it reduces complications during cataract surgeries.​ Hence, with the advantages of using toric intraocular lenses, rising ophthalmic issues, and increasing cases of cataracts in the diabetic population, the segment is expected to grow at a good pace during the forecast period.​


Competitive Landscape

The European intraocular lens market is fragmented, due to the presence of numerous market players. Major market players are focusing on partnerships, while signing agreements to enhance their market presence. The major players include Novartis AG (Alcon), Bausch Health Companies Inc. (Bausch + Lomb), Carl Zeiss Meditec AG, EyeKon Medical Inc., Hoya Corporation, HumanOptics AG, Johnson and Johnson Vision Care Inc., Lenstec Inc., Rayner, and STAAR Surgical Company. Furthermore, product innovation and technological advancements are expected to attract new market players.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Ophthalmic Disorders

      2. 4.2.2 Increasing Cases of Cataract in the Diabetic Population

      3. 4.2.3 Rising Adoption of Advanced Premium IOLs

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of IOLs

      2. 4.3.2 Lack of Reimbursement Policies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Product

      1. 5.1.1 Monofocal Intraocular Lens

      2. 5.1.2 Accommodative Intraocular Lens

      3. 5.1.3 Multifocal Intraocular Lens

      4. 5.1.4 Toric Intraocular Lens

    2. 5.2 End Users

      1. 5.2.1 Ophthalmic Clinics

      2. 5.2.2 Hospitals

      3. 5.2.3 Ambulatory Clinics

      4. 5.2.4 Research Institutes

    3. 5.3 Geography

      1. 5.3.1 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe


    1. 6.1 Company Profiles

      1. 6.1.1 Novartis AG (Alcon)

      2. 6.1.2 Bausch Health Companies Inc. (Bausch + Lomb)

      3. 6.1.3 Carl Zeiss Meditec AG

      4. 6.1.4 EyeKon Medical Inc.

      5. 6.1.5 Hoya Corporation

      6. 6.1.6 HumanOptics AG

      7. 6.1.7 Johnson & Johnson Surgical Vision, Inc.

      8. 6.1.8 Lenstec Inc.

      9. 6.1.9 Rayner

      10. 6.1.10 STAAR Surgical Company

    2. *List Not Exhaustive

**Competitive Landscape covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Intraocular Lens Market market is studied from 2018 - 2026.

The Europe Intraocular Lens Market is growing at a CAGR of 5% over the next 5 years.

Novartis AG (Alcon), Bausch Health Companies Inc. (Bausch + Lomb), Carl Zeiss Meditec AG, EyeKon Medical Inc., Johnson & Johnson Surgical Vision, Inc. are the major companies operating in Europe Intraocular Lens Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!